Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells

被引:0
|
作者
B. Santos-Carballal
L. J. Aaldering
M. Ritzefeld
S. Pereira
N. Sewald
B. M. Moerschbacher
M. Götte
F. M. Goycoolea
机构
[1] Institute of Plant Biology and Biotechnology (IBBP),Department of Gynecology and Obstetrics
[2] University of Münster,Markus Ritzefeld: Department of Chemistry
[3] Organic and Bioorganic Chemistry,undefined
[4] Bielefeld University,undefined
[5] Universitätsstrasse 25,undefined
[6] University of Münster,undefined
[7] Albert-Schweitzer-Campus 1,undefined
[8] Imperial College London,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cancer gene therapy requires the design of non-viral vectors that carry genetic material and selectively deliver it with minimal toxicity. Non-viral vectors based on cationic natural polymers can form electrostatic complexes with negatively-charged polynucleotides such as microRNAs (miRNAs). Here we investigated the physicochemical/biophysical properties of chitosan–hsa-miRNA-145 (CS–miRNA) nanocomplexes and the biological responses of MCF-7 breast cancer cells cultured in vitro. Self-assembled CS–miRNA nanocomplexes were produced with a range of (+/−) charge ratios (from 0.6 to 8) using chitosans with various degrees of acetylation and molecular weight. The Z-average particle diameter of the complexes was <200 nm. The surface charge increased with increasing amount of chitosan. We observed that chitosan induces the base-stacking of miRNA in a concentration dependent manner. Surface plasmon resonance spectroscopy shows that complexes formed by low degree of acetylation chitosans are highly stable, regardless of the molecular weight. We found no evidence that these complexes were cytotoxic towards MCF-7 cells. Furthermore, CS–miRNA nanocomplexes with degree of acetylation 12% and 29% were biologically active, showing successful downregulation of target mRNA expression in MCF-7 cells. Our data, therefore, shows that CS–miRNA complexes offer a promising non-viral platform for breast cancer gene therapy.
引用
收藏
相关论文
共 50 条
  • [1] Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells
    Santos-Carballal, B.
    Aaldering, L. J.
    Ritzefeld, M.
    Pereira, S.
    Sewald, N.
    Moerschbacher, B. M.
    Goette, M.
    Goycoolea, F. M.
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [2] Cytotoxicity Enhancement in MCF-7 Breast Cancer Cells with Depolymerized Chitosan Delivery of α-Mangostin
    Herdiana, Yedi
    Wathoni, Nasrul
    Shamsuddin, Shaharum
    Muchtaridi, Muchtaridi
    [J]. POLYMERS, 2022, 14 (15)
  • [3] Analysis of Gene Network in MCF-7 Human Breast Cancer Cells
    Shiraishi, Ryohei
    Nakakuki, Takashi
    [J]. 2012 12TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS), 2012, : 1527 - 1530
  • [4] Delivery and release of microRNA-34a into MCF-7 breast cancer cells using spherical nucleic acid nanocarriers
    Li, Hui
    Shen, Wei
    Lam, Michael Hon-Wah
    Liang, Haojun
    [J]. NEW JOURNAL OF CHEMISTRY, 2017, 41 (13) : 5255 - 5258
  • [5] Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells
    Ravikumara, Neralakere Ramanna
    Madhusudhan, Basavaraj
    [J]. PURE AND APPLIED CHEMISTRY, 2011, 83 (11) : 2027 - 2040
  • [6] Development and Characterization of Chitosan-Pluronic Nanoparticles for Tamoxifen Delivery and Cytotoxicity to MCF-7 Cells
    Othayoth, Rajath
    Karthik, Varshini
    Kumar, K. Santhosh
    [J]. 2013 INTERNATIONAL CONFERENCE ON ADVANCED NANOMATERIALS AND EMERGING ENGINEERING TECHNOLOGIES (ICANMEET), 2013, : 394 - 401
  • [7] AROMATASE GENE IS AMPLIFIED IN MCF-7 HUMAN BREAST-CANCER CELLS
    ZHOU, DJ
    WANG, JF
    CHEN, E
    MURAI, J
    SIITERI, PK
    CHEN, SU
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 46 (02): : 147 - 153
  • [8] Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines
    Dhiman, HK
    Ray, AR
    Panda, AK
    [J]. BIOMATERIALS, 2004, 25 (21) : 5147 - 5154
  • [9] Prolidase in human breast cancer MCF-7 cells
    Palka, JA
    Phang, JM
    [J]. CANCER LETTERS, 1998, 127 (1-2) : 63 - 70
  • [10] Comparison of the properties of human breast cancer cells: MCF-7 and MCF-7 cells selected for resistance to etoposide
    Cory, AH
    Cory, JG
    [J]. ADVANCES IN ENZYME REGULATION, VOL 41, 2001, 41 : 177 - 188